Trial Profile
A phase I trial of IONIS-FXI-LRx for prevention of thrombosis.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Fesomersen (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 09 Mar 2017 New trial record